---
title: "Fusion Antibodies Sells Antibody IP to Finn Therapeutics in £250,000 Deal"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/280966646.md"
description: "Fusion Antibodies Sells Antibody IP to Finn Therapeutics in £250,000 Deal"
datetime: "2026-03-30T06:38:16.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/280966646.md)
  - [en](https://longbridge.com/en/news/280966646.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/280966646.md)
generator: "portal-rs"
---

# Fusion Antibodies Sells Antibody IP to Finn Therapeutics in £250,000 Deal

Fusion Antibodies Sells Antibody IP to Finn Therapeutics in £250,000 Deal

### Related Stocks

- [IPA.US](https://longbridge.com/en/quote/IPA.US.md)

## Related News & Research

- [American Fusion Inc. (OTCQB: AMFN) Reaches Major Intellectual Property Milestone with 100 Patent Applications Pending | AMFN Stock News](https://longbridge.com/en/news/296770681.md)
- [BioXcel Therapeutics Adds $1.25 Million Oaktree Term Loans, Wins Liquidity Covenant Relief](https://longbridge.com/en/news/296905092.md)
- [Sarepta Therapeutics (SRPT) Could Be 30% Undervalued After Elevidys Progress Hopes](https://longbridge.com/en/news/297287791.md)
- [11:18 ETVeteran First-Chair Trial Lawyer  Mary-Olga "Mo" Lovett Joins McKool Smith](https://longbridge.com/en/news/297065642.md)
- [Primecap Management Co. CA Makes New Investment in Palvella Therapeutics, Inc. $PVLA](https://longbridge.com/en/news/297156499.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**